Hikma Pharmaceuticals (LON:HIK) Share Price Crosses Above 200 Day Moving Average - Here's What Happened

Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,921.22 ($24.42) and traded as high as GBX 1,944 ($24.71). Hikma Pharmaceuticals shares last traded at GBX 1,938 ($24.64), with a volume of 178,291 shares traded.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank raised Hikma Pharmaceuticals to a "buy" rating and raised their price target for the company from GBX 2,100 ($26.70) to GBX 2,400 ($30.51) in a report on Monday, September 2nd.

Hikma Pharmaceuticals Price Performance

The firm's 50 day simple moving average is GBX 1,907.09 and its two-hundred day simple moving average is GBX 1,921.22. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27. The firm has a market capitalization of £4.25 billion, a P/E ratio of 2,944.62, a P/E/G ratio of 2.38 and a beta of 0.41.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.